Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of sunitinib base and synthesis method, which is applied in the directions of drug combination, organic chemistry, antitumor drugs, etc., can solve the problems of incomplete hydrolysis, and achieve the effects of reduced cost, high yield and simple post-processing
Inactive Publication Date: 2008-12-31
NANJING UNIV OF TECH
View PDF0 Cites 17 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0011] Technical problem: In the methods mentioned above, there is one-step hydrolysis of esters,
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] 0.70 g (3.59 mmol) of ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate, 0.45 g (3 mmol) of 5-fluoroindol-2-one, 9mL of ethanol and several drops of piperidine were reacted at 80°C for 3 hours under nitrogen protection, and a large amount of solids appeared. After cooling, filter with suction, wash the filter cake with ethanol, and vacuum-dry to obtain 0.88 g of solid, with a yield of 89.3%.
[0038] Starting from ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate, the traditional three-step reaction is combined into two, and the yield of each step is high, which greatly improves the reaction yield.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Melting point
aaaaa
aaaaa
Melting point
aaaaa
aaaaa
Login to view more
Abstract
A Sunitinib alkali synthetic methodsynthesis method makes improvement on the synthetic route of Sunitinib alkali so as to avoid the problems in the traditional route and shorten the synthetic route by one step. From the initial synthesis idea, the following two steps are improved in the design: (1), the key intermediate 5-formyl -2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester and 5-fluoroindole-2-ketone are directly condensed in ethanol with piperidine serving as catalyst so as to obtain 5-((5-fluoro-2-oxo-indole-3-alkenyl) methyl)-2,4- dimethyl-1H-pyrrole-3-carboxylate; (2), under the effect of a specific catalyst, the 5-((5-fluoro-2-oxo-indole-3-alkenyl) methyl)-2,4- dimethyl-1H-pyrrole-3-carboxylate is further ammonolyzed with 2-(diethylamino) ethylenediamine in ethylene glycol dimethyl ether so as to directly obtain the Sunitinib alkali; the two products are confirmed through NMR spectrum. The two-step reaction has relatively high yield and shortens the reaction process so as to greatly reduce production costs.
Description
technical field [0001] The invention relates to an improved method for preparing sunitinib base, which belongs to Background technique [0002] Sunitinib malate is a small molecule compound that can inhibit a variety of tyrosine kinase receptors, some of which are related to tumor growth, pathological angiogenesis and cancer metastasis. Tyrosine kinase receptors for platelet-derived growth factor receptor, stem cell factor receptor, Fms-like tyrosine kinase-3, colony-stimulating factor receptor type I, and glial cell line-derived neurotrophic factor receptor It blocks the blood and nutrient supply for tumor cell growth, thereby producing anti-angiogenic and anti-tumor effects. [0003] Phase III clinical trial results confirmed that sunitinib malate can delay the development of tumors in patients with gastrointestinal stromal tumors who have become resistant (or intolerant) to imatinib (imatinib, Gleevec) treatment, significantly reducing patient mortality. It also has a ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more